Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96184023 | 9618402 | 3 | F | 20160823 | 20131014 | 20160906 | EXP | CA-RANBAXY-2013US-74037 | RANBAXY | ST-ONGE M, AJMO I, POIRIER D, LALIBERTE M. L-CARNITINE FOR THE TREATMENT OF A CALCIUM CHANNEL BLOCKER AND METFORMIN POISONING. J MED TOXICOL. 2013;SEP;9(3):266-9 | 68.00 | YR | M | Y | 80.00000 | KG | 20160906 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96184023 | 9618402 | 1 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | UNK | 77974 | TABLET | |||||||||
| 96184023 | 9618402 | 2 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 96184023 | 9618402 | 3 | SS | ETHANOL | ALCOHOL | 1 | Unknown | UNK | 0 | ||||||||||
| 96184023 | 9618402 | 4 | C | Acetylsalicylic acid | ASPIRIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 96184023 | 9618402 | 5 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Unknown | UNK | U | 0 | |||||||||
| 96184023 | 9618402 | 6 | C | GLYBURIDE. | GLYBURIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 96184023 | 9618402 | 7 | C | IRBESARTAN. | IRBESARTAN | 1 | Unknown | UNK | U | 0 | |||||||||
| 96184023 | 9618402 | 8 | C | Tamsulosin | TAMSULOSIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 96184023 | 9618402 | 9 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 96184023 | 9618402 | 1 | Product used for unknown indication |
| 96184023 | 9618402 | 2 | Product used for unknown indication |
| 96184023 | 9618402 | 3 | Product used for unknown indication |
| 96184023 | 9618402 | 4 | Product used for unknown indication |
| 96184023 | 9618402 | 5 | Product used for unknown indication |
| 96184023 | 9618402 | 6 | Product used for unknown indication |
| 96184023 | 9618402 | 7 | Product used for unknown indication |
| 96184023 | 9618402 | 8 | Product used for unknown indication |
| 96184023 | 9618402 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 96184023 | 9618402 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 96184023 | 9618402 | Hyperglycaemia | |
| 96184023 | 9618402 | Intentional overdose | |
| 96184023 | 9618402 | Metabolic acidosis | |
| 96184023 | 9618402 | Oliguria | |
| 96184023 | 9618402 | Shock | |
| 96184023 | 9618402 | Suicide attempt | |
| 96184023 | 9618402 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |